PTEN and prostate neoplasm: The role of PTEN inhibition as a cause of cancer cell senescence strengthened further in vivo research on p53 wild type MDA PCa-2b xenograft prostate tumors, in which chemical targeting of PTEN resulted in an increased expression of SA-β-Gal and decreased expression of Ki67 [170].